How does regular exercise affect dyspnoe (TDI) and quality of life (CAT) of COPD-patients 1 year after an inpatient pulmonary rehabilitation (PR)? Source: International Congress 2015 – Latest insights into pulmonary rehabilitation Year: 2015
Does disease affect outcome of pulmonary rehabilitation (PR)? Source: Annual Congress 2009 - New treatment and outcome measures for pulmonary rehabilitation Year: 2009
Effect of pulmonary rehabilitation (PR) in subjects with normocapnic respiratory failure (NRF) Source: Eur Respir J 2003; 22: Suppl. 45, 348s Year: 2003
Inspiratory muscle training (IMT) as an adjunct to pulmonary rehabilitation (PR) in patients with severe COPD Source: Annual Congress 2012 - New adjuncts and modalities in pulmonary rehabilitation Year: 2012
Effects of routine inspiratory muscle training (IMT) as add-on to pulmonary rehabilitation (PR) in COPD Source: International Congress 2015 – Latest insights into pulmonary rehabilitation Year: 2015
Effects of a pulmonary rehabilitation (PR) in outpatients with asthma Source: Eur Respir J 2002; 20: Suppl. 38, 183s Year: 2002
Metabolic syndrome (MS) in COPD patients entering pulmonary rehabilitation (PR) Source: Annual Congress 2008 - Assessing profiles of rehabilitation candidates Year: 2008
Are there differences in response to pulmonary rehabilitation (PR) in idiopathic pulmonary fibrosis (IPF) and COPD patients? Source: International Congress 2017 – New insights into pulmonary rehabilitation in patients with chronic lung diseases Year: 2017
Buteyko technique (BT) as an adjunct in pulmonary rehabilitation (PR) in patients with asthma and dysfunctional breathing – First results of an ongoing prospective controlled study Source: Annual Congress 2012 - New adjuncts and modalities in pulmonary rehabilitation Year: 2012
Influence of cigarette smoking (CS) on the pulmonary complaints (PC), function of the external breathing (FEB) and quality of life (QL) in the practically healthy persons Source: Eur Respir J 2007; 30: Suppl. 51, 165s Year: 2007
Does pulmonary rehabilitation (PR) influence patient‘s perceptions of disease? Source: Annual Congress 2012 - The best posters in pulmonary rehabilitation and chronic care Year: 2012
Changes of active expiration respiratory muscle (RM) in men with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2011 - Respiratory and skeletal muscle assessment in health and disease Year: 2011
Measurement of improved activities after pulmonary rehabilitation (PR) in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 223s Year: 2001
Does the initial BODE influence in the response at short and long term of a pulmonary rehabilitation (PR) program in COPD patients? Source: Annual Congress 2010 - Outcomes and predictors of the sucess of pulmonary rehabilitation in chronic respiratory disease Year: 2010
Asthma control (AC) 1 year after pulmonary rehabilitation (PR) Source: Annual Congress 2011 - Challenges in rehabilitation: some old dilemmas revisited with some solutions? Year: 2011
CAT (COPD assessment test) as outcome parameter of pulmonary rehabilitation (PR) in COPD Source: Annual Congress 2011 - What do individuals know about their disease? Educational needs, the psychological impact of chronic respiratory disease and health-related quality of life Year: 2011
Pulmonary function test (PT) and physical fitness (F) in asthmatic children Source: Eur Respir J 2005; 26: Suppl. 49, 395s Year: 2005
Characterization of physical activity (PA) patterns by use of multiple accelerometers in COPD patients undergoing long-term oxygen therapy (LTOT) within a pulmonary rehabilitation (PR) program Source: Annual Congress 2010 - Physical activity, exercise regimes and outcomes for chronic respiratory disease Year: 2010
The effect of ambulatory oxygen (AO2 ) in patients during pulmonary rehabilitation (PR) Source: Eur Respir J 2005; 26: Suppl. 49, 181s Year: 2005
Enhanced training on how to use a dry powder inhaler (DPI) improves the inhalation manoeuvre (IM) of patients with asthma (child 6–17 yrs and adult >17 yrs) or COPD and in healthy adults (HA) when they use a Spiromax® (S) and Turbuhaler® (T) DPI Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics Year: 2013